319 related articles for article (PubMed ID: 10524455)
21. Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea.
Ma Q; Wyszynski DF; Farrell JJ; Kutlar A; Farrer LA; Baldwin CT; Steinberg MH
Pharmacogenomics J; 2007 Dec; 7(6):386-94. PubMed ID: 17299377
[TBL] [Abstract][Full Text] [Related]
22. Absolute Reticulocyte Count Acts as a Surrogate for Fetal Hemoglobin in Infants and Children with Sickle Cell Anemia.
Meier ER; Byrnes C; Weissman M; Lee YT; Miller JL
PLoS One; 2015; 10(9):e0136672. PubMed ID: 26366562
[TBL] [Abstract][Full Text] [Related]
23. Emerging science of hydroxyurea therapy for pediatric sickle cell disease.
Green NS; Barral S
Pediatr Res; 2014 Jan; 75(1-2):196-204. PubMed ID: 24252885
[TBL] [Abstract][Full Text] [Related]
24. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
[TBL] [Abstract][Full Text] [Related]
25. Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease.
Green NS; Barral S
Pediatr Blood Cancer; 2011 Feb; 56(2):177-81. PubMed ID: 20830771
[TBL] [Abstract][Full Text] [Related]
26. Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes.
Sheehan VA; Luo Z; Flanagan JM; Howard TA; Thompson BW; Wang WC; Kutlar A; Ware RE;
Am J Hematol; 2013 Jul; 88(7):571-6. PubMed ID: 23606168
[TBL] [Abstract][Full Text] [Related]
27. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease.
Hebert N; Rakotoson MG; Bodivit G; Audureau E; Bencheikh L; Kiger L; Oubaya N; Pakdaman S; Sakka M; Di Liberto G; Chadebech P; Vingert B; Pirenne F; Galactéros F; Cambot M; Bartolucci P
Am J Hematol; 2020 Nov; 95(11):1235-1245. PubMed ID: 32681733
[TBL] [Abstract][Full Text] [Related]
28. Elevated fetal haemoglobin levels are associated with decreased incidence of retinopathy in adults with sickle cell disease.
Mian UK; Tang J; Allende APM; Heo M; Bernstein N; Vattappally L; Schoenfeld D; Minniti CP
Br J Haematol; 2018 Dec; 183(5):807-811. PubMed ID: 30417925
[TBL] [Abstract][Full Text] [Related]
29. Fetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents.
Habara AH; Shaikho EM; Steinberg MH
Am J Hematol; 2017 Nov; 92(11):1233-1242. PubMed ID: 28736939
[TBL] [Abstract][Full Text] [Related]
30. A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy.
Estepp JH; Smeltzer MP; Kang G; Li C; Wang WC; Abrams C; Aygun B; Ware RE; Nottage K; Hankins JS
Am J Hematol; 2017 Dec; 92(12):1333-1339. PubMed ID: 28913922
[TBL] [Abstract][Full Text] [Related]
31. Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin.
Ngo DA; Aygun B; Akinsheye I; Hankins JS; Bhan I; Luo HY; Steinberg MH; Chui DH
Br J Haematol; 2012 Jan; 156(2):259-64. PubMed ID: 22017641
[TBL] [Abstract][Full Text] [Related]
32. Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease.
Dover GJ; Charache S
Semin Oncol; 1992 Jun; 19(3 Suppl 9):61-6. PubMed ID: 1379374
[TBL] [Abstract][Full Text] [Related]
33. [From Hemoglobin SS to SF: interest of hydroxyurea in the management of sickle cell disease in two Congolese children and review of the literature].
Nkashama GM; Wakamb GK; Mulangu AM; Nkashama GM; Kupa BK; Numbi OL
Pan Afr Med J; 2015; 21():124. PubMed ID: 26327961
[TBL] [Abstract][Full Text] [Related]
34. Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease.
Zimmerman SA; Schultz WH; Davis JS; Pickens CV; Mortier NA; Howard TA; Ware RE
Blood; 2004 Mar; 103(6):2039-45. PubMed ID: 14630791
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide and cyclic GMP levels in sickle cell patients receiving hydroxyurea.
Nahavandi M; Tavakkoli F; Wyche MQ; Perlin E; Winter WP; Castro O
Br J Haematol; 2002 Dec; 119(3):855-7. PubMed ID: 12437671
[TBL] [Abstract][Full Text] [Related]
36. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea.
Steinberg MH; Lu ZH; Barton FB; Terrin ML; Charache S; Dover GJ
Blood; 1997 Feb; 89(3):1078-88. PubMed ID: 9028341
[TBL] [Abstract][Full Text] [Related]
37. Sickle cell paths converge on hydroxyurea.
Platt OS
Nat Med; 1995 Apr; 1(4):307-8. PubMed ID: 7585059
[No Abstract] [Full Text] [Related]
38. Whole exome sequencing identifies novel genes for fetal hemoglobin response to hydroxyurea in children with sickle cell anemia.
Sheehan VA; Crosby JR; Sabo A; Mortier NA; Howard TA; Muzny DM; Dugan-Perez S; Aygun B; Nottage KA; Boerwinkle E; Gibbs RA; Ware RE; Flanagan JM
PLoS One; 2014; 9(10):e110740. PubMed ID: 25360671
[TBL] [Abstract][Full Text] [Related]
39. Comparison of radial immunodiffusion and alkaline cellulose acetate electrophoresis for quantitating elevated levels of fetal hemoglobin (HbF): application to evaluating patients with sickle cell disease treated with hydroxyurea.
Schultz JC
J Clin Lab Anal; 1999; 13(2):82-9. PubMed ID: 10102137
[TBL] [Abstract][Full Text] [Related]
40. Negative Epistasis between Sickle and Foetal Haemoglobin Suggests a Reduction in Protection against Malaria.
Mmbando BP; Mgaya J; Cox SE; Mtatiro SN; Soka D; Rwezaula S; Meda E; Msaki E; Snow RW; Jeffries N; Geller NL; Makani J
PLoS One; 2015; 10(5):e0125929. PubMed ID: 25965586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]